Cardiff spinout developing new cell & gene therapies

Cardiff University spinout Broken String Biosciences is a genomics company with the goal of developing safer cell and gene therapies by assessing the stability of the genome. It is building a technology platform that accelerates the characterisation of novel genome editing technologies. This will unlock the next wave of cell & gene therapies. that are safer, more efficient, and affordable for patients.

Broken String Biosciences completed a six-month residency at the Illumina Accelerator in Cambridge in 2021 and raised Series Seed financing of c.£3m the same year. Attracting investors from the UK, Germany and the United States with strong links to academic and industrial collaborators, the company has subsequently doubled in size.

The company is now headquartered at the BioData Innovation Centre, Wellcome Genome Campus in Cambridge, and has established a wet-lab facility at nearby Chesterford Research Park. 

Policy area

Related case studies

Media Enquiries
Policy Enquiries

Follow us on Twitter